Differential expression of three t lymphocyte-activating CXC chemokines by human atheroma-associated cells

Journal of Clinical Investigation

Volumn 104, Issue 8, 1999, Pages 1041-1050

  Mach, François ^a   Sauty, Alain ^a   Iarossi, Albert S ^a   Sukhova, Galina K ^a   Neote, Kuldeep ^b   Libby, Peter ^a   Luster, Andrew D ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b PFIZER INC   (United States)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CHEMOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 39; INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ATHEROGENESIS; ATHEROMA; BLOOD VESSEL WALL; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOPATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

EID: 0032749367     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI6993     Document Type: Article

References (57)

1. Libby, P. 1995. Molecular bases of the acute coronary syndromes. Circulation. 91:2844-2850.
2. Ross, R. 1999. Atherosclerosis: an inflammatory disease. N. Engl. J. Med. 340:115-126.
3. Hansson, G.K., et al. 1988. Localization of T lymphocytes and macrophages in fibrous and complicated human atherosclerotic plaques. Atherosclerosis. 72:135-141.
4. Hansson, G.K. 1997. Cell-mediated immunity in atherosclerosis. Curr. Opin. Lipidol. 8:301-311.
5. Stemme, S., and Hansson, G.K. 1994. Immune mechanisms in athetogenesis. Ann. Med. 26:141-146.
6. Stemme, S., Rymo, L., and Hansson, G.K. 1991. Polyclonal origin of T lymphocytes in human atherosclerotic plaques. Lib. Invest. 65:654-660.
7. Stemme, S., et al. 1995. T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein. Proc. Natl. Acad. Sci. USA. 92:3893-3897.
8. Stemme, S., Holm J., and Hansson, G.K. 1992. T lymphocytes in human atheroscleroric plaques are memory cells expressing CD45RO and the integrin VLA-1. Arterioscler. Thromb. 12:206-211.
9. Hansson, G.K., et al. 1991. T lymphocytes inhibit the vascular response to injury. Proc. Natl. Acad. Sci. USA. 88:10530-10534.
10. Zhou, X., Paulsson, G., Stemme, S., and Hansson, G.K. 1998. Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice. J. Clin. Invest. 101:1717-1725.
11. Gupta, S., et al. 1997. IFN-gamma potentiates atherosclerosis in ApoE knock-out mice. J. Clin. Invest. 99:2752-2761.
12. Luster, A.D. 1998. Chemokines: chemotactic cytokines that mediate inflammation. N. Engl. J. Med. 338:436-445.
13. Clark-Lewis, I., Dewald, B., Geiser, T., Moser, B., and Baggiolini, M. 1993. Platelet factor 4 binds to interleukin 8 receptors and activates neutrophils when its N terminus is modified with Glu-Leu-Arg. Proc. Natl. Acad. Sci. USA. 90:3574-3577
14. Taub, D.D., et al. 1993. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and T lymphocytes and promotes T cell adhesion to endothclial cells. J. Exp. Med. 177:1809-1814.
15. Loetsrher, M., et al. 1996. Chemokine receptor specific for IP10 and Mig: structute, function, and expression in activated T-lymphocytes. J. Exp. Med. 184:963-969.
16. Liao, F., et al. 1995. Human Mig chemokine: biochemical and functional characterization. J. Exp. Med. 182:1301-1314.
17. Farber, J.M. 1997. Mig and IP-10: CXC chemokines that target lymphocytes. J. Leukoc. Biol. 61:246-257.
18. Cole, K.E., et al. 1998. Interferon-inducible T cell alpha chemoattractant (I-TAC): a novel non-ELR CXC chemokine with potent activity on activated T cells through selective high affinity binding to CXCR3. J. Exp. Med. 187:2009-2021.
19. Loetscher, P., et al. 1998. CCR5 is characteristic of Th1 lymphocytes. Nature. 391:344-345.
20. Qin, S., et al. 1998. The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions. J. Clin. Invest. 101:746-754.
21. Sallusto, F., Lenig, D., Mackay, C.R., and Lanzavecchia, A. 1998. Flexible programs of chemokine receptor expression on human polarized T helper 1 and 2 lymphocytes. J. Exp. Med. 187:875-883.
22. Bonecchi, R., et al. 1998. Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s. J. Exp. Med. 187:129-134.
23. Gottlieb, A.B., Luster, A.D., Posnett, D.N., and Carter, D.M. 1988. Detection of a gamma interferon-induced protein IP-10 in psoriatic plaques. J. Exp.Med. 168:941-948.
24. Kaplan, G., Luster, A.D., Hancock, G., and Cohn, Z.A. 1987. The expression of a gamma interferon-induced protein (IP-10) in delayed immune responses in human skin. J. Exp. Med. 166:1098-1108.
25. Agostini, C., et al. 1998. Involvement of the IP-10 chemokine in sarcoid granulomatous reactions. J. Immunol. 161:6413-6420.
26. Lahrtz, F., et al. 1997. Chemotactic activity on mononuclear cells in the cerebrospinal fluid of patients with viral meningitis is mediated by imerferon-gamma inducible protein-10 and monocyte chemotactic protein-1. Eur. J. Immunol. 27:2484-2489.
27. Sauty, A., et al. 1999. The T cell-specific CXC chemokines IP-10, Mig, and 1-TAC are expressed by activated human bronchial epithelial cells. J. Immunol. 162:3549-3558.
28. Nelken, N.A., Coughlin, S.R., Gordon, D., and Wilcox, J.N. 1991. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88:1121-1127.
29. Boisvert, W.A., Santiago, R., Curtiss, L.K., and Terkeltaub, R.A. 1998. A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice. J. Clin. Invest. 101:353-363.
30. Wang, J.M., et al. 1991. Expression of monocyte chemotactic protein and interleukin-8 by cytokine-activated human vascular smooth muscle cells. Arteriosder. Thromb. 11:1166-1174.
31. Berkhout, T.A., et al. 1997. Cloning, in vitro expression, and functional characterization of a novel human CC chemokine of the monocyte chemotactic protein (MCP) family (MCP-4) that binds and signals through the CC chemokine receptor 2B. J. Biol. Chem. 272:16404-16413.
32. Jordan, N.J., et al. 1997. Chemokine production by human vascular smooth muscle cells: modulation by IL-13. Br. J. Pharmacol. 122:749-757.
33. Klouche, M., et al. 1998. Atherogenic properties of enzymatically degraded LDL: selective induction of MCP-1 and cytotoxic effects on human macrophages. Arteriosder. Thromb. Vasc. Biol. 18:1376-1385.
34. Wang, N., et al. 1996. Interleukin 8 is induced by cholesterol loading of macrophages and expressed by macrophage foam cells in human atheroma. Biol. Chem. 271:8837-8842.
35. Rus, H.G., Vlaicu, R., and Niculescu, F. 1996. Interleukin-6 and interleukin-8 protein and gene expression in human arterial atherosclerotic wall. Atherosclerosis. 127:263-271.
36. Gu, L., et al. 1998. Absence of monocyte chemoatrracrant protein-1 reduces atherosclerosis in low density lipoprorein receptor-deficient mice. Mol. Cell. 2:275-281.
37. Boring, L., Gosling, J., Cleary, M., and Charo, I.F. 1998. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature. 394:894-897.
38. Mach, F., et al. 1997. Functional CD40 ligand is expressed on human vascular endothelial cells, smooth muscle cells, and macrophages: implications for CD40-CD40 ligand signaling in atherosclerosis. Proc. Natl. Acad. Sci. USA. 94:1931-1936.
39. Mach, F., Schonbeck, U., Sukhova, G.K., Atkinson, E., and Libby, P. 1998. Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394:200-203.
40. Wang, B.Y., et al. 1999. Regression of atherosclerosis: role of nitric oxide and apoptosis. Circulation. 99:1236-1241.
41. Kouretas, P.C., et al. 1999.Nonanticoagulant heparin prevents coronary endothelial dysfunction after brief ischemia-reperfusion injury in the dog. Circulation. 99:1062-1068.
42. Luster, A.D., Greenberg, S.M., and Leder, P. 1995. The IP-10 chemokine binds to a specific cell surface heparan sulfate site shared with platelet factor 4 and inhibits endothelial cell proliferation. J. Exp. Med. 182:219-231.
43. Mazzei, G.J., et al. 1995. Recombinant soluble trimeric CD40 ligand is biologically active. J. Biol. Chem. 270:7025-7028.
44. Gimbrone, M.A., Jr., Cotran, R.S., and Folkman, J. 1974. Human vascular endothelial cells in culture. Growth and DNA synthesis. J. Cell Biol. 60:673-684.
45. Libby, P., and O'Brien, K.V. 1983. Culture of quiescent arterial smooth muscle cells in a defined serum-free medium. J. Cell. Physiol. 115:217-223.
46. Galis, Z.S., Sukhova, G.K., Lark, M.W., and Libby, P. 1994. Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J. Clin. Invest. 94:2493-2503.
47. Peng, H.B., Rajavashisth, T.B., Libby, P., and Liao, J.K. 1995. Nitric oxide inhibits macrophage-colony stimulating factor gene transcription in vascular endothelial cells. J. Biol. Chem. 270:17050-17055.
48. Zeiher, A.M., Fisslthaler, B., Schray-Utz, B., and Busse, R. 1995. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. Circ. Res 76:980-986.
49. Emeson, E.E., and Robertson, A.L., Jr. 1988. T lymphocytes in aortic and coronary intimas. Their potential role in atherogenesis. Am. J. Pathol. 130:369-376.
50. Xu, Q.B., Oberhuber, G., Gruschwitz, M., and Wick, G. 1990. Immunology of atherosclerosis: cellular composition and major histocompatibility complex class II antigen expression in aortic intima, fatty streaks, and atherosclerotic plaques in young and aged human specimens. Clin. Immunol. Immunopathol. 56:344-359.
51. Hansson, G.K., Holm, J., and Jonasson, L. 1989. Detection of activated T lymphocytes in the human atherosclerotic plaque. Am. J. Pathol. 135:169-175.
52. Dansky, H.M., Charlton, S.A., Harper, M.M., and Smith, J.D. 1997. T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc. Natl. Acad. Sci. USA. 94:4642-4646.
53. De Caterina, R., et al. 1995. Nitric oxide decreases cytokine-induced endothelial activation. Nitric oxide selectively reduces endothelial expression of adhesion molecules and proinflammatory cytokines. J. Clin. Invest. 96:60-68.
54. Kornbluth, R.S., Kee, K., and Richman, D.D. 1998. CD40 ligand (CD154) stimulation of macrophages to produce HIV-1-suppressive β-chemokines. Proc. Natl. Acad. Sci. USA. 95:5205-5210.
55. Wang, X., Yue, T.-L., Ohlstein, E.H., Sung, C-P., and Feuerstein, G.Z. 1996. Interferon-inducible protein-10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J. Biol. Chem. 271:24286-24293.
56. Luster, A.D., Cardiff, R.D., MacLean, J.A., Crowe, K., and Granstein, R.D. 1998. Delayed wound healing and disorganized neovascularization in rransgenic mice expressing the IP-10 chemokine. Proc. Assoc. Am. Physicians. 110:183-196.
57. Gangur, V., Simons, F.E., and Hayglass, K.T. 1998. Human IP-10 selectively promotes dominance of polyclonally activated and environmental antigen-driven IFN-gamma over IL-4 responses. FASEB J. 12:705-713.